We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer

    Background and aims

    We aimed to identify mucin-microbiome signatures sha** the tumor microenvironment in gastric adenocarcinomas and clinical...

    Baptiste Oosterlinck, Hannah Ceuleers, ... Annemieke Smet in Microbiome
    Article Open access 21 April 2023
  2. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei

    Background

    Pseudomyxoma peritonei (PMP) is a rare peritoneal mucinous carcinomatosis with largely unknown underlying molecular mechanisms....

    Antonio Romero-Ruiz, Melissa Granados-Rodríguez, ... Álvaro Arjona-Sánchez in Biological Procedures Online
    Article Open access 15 May 2024
  3. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance

    There has been a surge of interest in recent years in understanding the intricate mechanisms underlying cancer progression and treatment resistance....

    Shabnam Malik, Mohammed Sikander, ... Subhash C. Chauhan in Cancer and Metastasis Reviews
    Article 18 March 2024
  4. Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. This is due to its aggressive course, late diagnosis and its intrinsic drugs...

    Antonio Agostini, Ilaria Guerriero, ... Carmine Carbone in Journal of Translational Medicine
    Article Open access 23 November 2023
  5. Four functional profiles for fibre and mucin metabolism in the human gut microbiome

    Background

    With the emergence of metagenomic data, multiple links between the gut microbiome and the host health have been shown. Deciphering these...

    Simon Labarthe, Sandra Plancade, ... Beatrice Laroche in Microbiome
    Article Open access 20 October 2023
  6. Compendium of 5810 genomes of sheep and goat gut microbiomes provides new insights into the glycan and mucin utilization

    Background

    Ruminant gut microbiota are critical in ecological adaptation, evolution, and nutrition utilization because it regulates energy metabolism,...

    Ke Zhang, Chong He, ... Yulin Chen in Microbiome
    Article Open access 06 June 2024
  7. Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model

    Background

    Post-weaning diarrhea in piglets reduces growth performance and increases mortality, thereby causing serious economic losses. The...

    Bing **a, Ruqing Zhong, ... Hongfu Zhang in Microbiome
    Article Open access 31 August 2022
  8. Stable expression of mucin glycoproteins GP40 and GP15 of Cryptosporidium parvum in Toxoplasma gondii

    Background

    Cryptosporidium spp. are common protozoa causing diarrhea in humans and animals. There are currently only one FDA-approved drug and no...

    Muxiao Li, **aohua Sun, ... Yaqiong Guo in Parasites & Vectors
    Article Open access 15 February 2024
  9. An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1

    Background

    Lung cancer cells overexpress mucin 1 (MUC1) and active subunit MUC1-CT. Although a peptide blocks MUC1 signalling, metabolites targeting...

    Fareesa Aftab, Alice Rodriguez-Fuguet, ... Wen Cai Zhang in British Journal of Cancer
    Article Open access 21 February 2023
  10. Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study

    Mucin-1 (MUC-1) is a transmembrane glycoprotein, which bears many similarities between dogs and humans. Since the existence of animal models is...

    Rana Vafaei, Mitra Samadi, ... Leila Farahmand in Cancer Cell International
    Article Open access 09 January 2022
  11. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease

    To elucidate the relevance of gut dysbiosis in Parkinson’s disease (PD) in disease progression, we made random forest models to predict the...

    Hiroshi Nishiwaki, Mikako Ito, ... Kinji Ohno in npj Parkinson's Disease
    Article Open access 01 June 2022
  12. Muc2 mucin o-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway

    Background

    Ulcerative colitis (UC) is a chronic inflammatory disease of the intestine characterized by a compromised intestinal epithelial barrier....

    Juan Wei, Chunyan Chen, ... Fangyu Wang in Journal of Translational Medicine
    Article Open access 08 November 2023
  13. A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis

    Background

    Compared to conventional adenocarcinoma (CA), mucin-producing adenocarcinoma (MPA) is an uncommon histological subtype and is usually...

    Qiang Wang, Junbin Zhong, ... Jie Cao in BMC Cancer
    Article Open access 23 October 2021
  14. The mucin-like, secretory type-I transmembrane glycoprotein GP900 in the apicomplexan Cryptosporidium parvum is cleaved in the secretory pathway and likely plays a lubrication role

    Background

    Cryptosporidium parvum is a zoonotic parasite and member of the phylum Apicomplexa with unique secretory organelles, including a rhoptry,...

    **aohui Li, Jigang Yin, ... Guan Zhu in Parasites & Vectors
    Article Open access 17 May 2022
  15. The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections

    Motivation

    With the coronavirus pandemic still raging, prophylactic-nasal and early-treatment throat-sprays could help prevent infection and reduce...

    David Needham in Pharmaceutical Research
    Article 28 December 2021
  16. Pancreatic Cancer: Pursuit of Mucins from Progression to Prognosis

    Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by a late diagnosis, poor survival, and limited treatment options....
    Ashu Shah, Sophia G. Kisling, Surinder K. Batra in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  17. Immunohistochemical detection of MUC5AC and MUC5B mucins in ferrets

    Objective

    Cystic fibrosis (CF) is a genetic condition that causes abnormal mucus secretions in affected organs. MUC5AC and MUC5B are gel-forming...

    David K. Meyerholz, Mariah R. Leidinger, ... John F. Engelhardt in BMC Research Notes
    Article Open access 22 June 2023
  18. The potential role of ocular and otolaryngological mucus proteins in myalgic encephalomyelitis/chronic fatigue syndrome

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness associated with a constellation of other symptoms. While the...

    Kaylin Huitsing, Tara Tritsch, ... Travis J. A. Craddock in Molecular Medicine
    Article Open access 03 January 2024
  19. Pancreatic Cancer: Pursuit of Mucins from Progression to Prognosis

    Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by a late diagnosis, poor survival, and limited treatment options....
    Ashu Shah, Sophia G. Kisling, Surinder K. Batra in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.